FDA chief struggles to explain slow response on baby formula
Headline from WFMZ Allentown
The head of the Food and Drug Administration testified about a series of setbacks that led to a months-long delay in inspecting the plant at the center of a nationwide
WFMZ Allentown's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
The head of the Food and Drug Administration is preparing to tell lawmakers about events that led to a months-long gap before inspecting the plant at the center of a
The head of the Food and Drug Administration testified about a series of setbacks that led to a months-long delay in inspecting the plant at the center of a nationwide
WASHINGTON (AP) — The head of the Food and Drug Administration faced bipartisan fury from House lawmakers Wednesday over months of delays investigating problems at the nation's largest baby formula
The head of the Food and Drug Administration is preparing to tell lawmakers about events that led to a months-long gap before inspecting the plant at the center of a nationwide baby formula shortage.
Federal plans to inspect a baby formula factory linked to the nationwide shortage were slowed by COVID-19, scheduling conflicts, and other logistical problems, according to prepared testimony from the head of the FDA.
Top officials at the Food and Drug Administration admitted they took too long to respond to a baby formula shortage and were hobbled by bad decisions and COVID-related problems, including a whistleblower report about a formula factory that was lost in the mail.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
FDA chief struggles to explain slow response on baby formula | Since Then
